![Anja Koenig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anja Koenig
Directeur/Membre du Conseil chez
SENSIRION HOLDING AG
Fortune : 123 940 $ au 31/05/2026
Profil
Anja Koenig currently works at Sensirion Holding AG, as Independent Non-Executive Director from 2021, Forendo Pharma Oy, as Director, Ribon Therapeutics, Inc., as Director from 2019, Mediar Therapeutics, Inc., as Director, Novartis Venture Fund, as Global Head from 2017, Swiss National Science Foundation, as Member-Foundation Board, and Arctos Medical AG, as Member-Supervisory Board.
Dr. Koenig also formerly worked at Oxagen Ltd., as Non-Executive Director, Nabriva Therapeutics GmbH, as Director-Supervisory Board, MerLion Pharmaceuticals Pte Ltd., as Director, F2G Ltd., as Non-Executive Director, Nxera Pharma UK Ltd., as Non-Executive Director, Covagen AG, as Director-Supervisory Board, Diagnoplex SA, as Director-Executive Board from 2009 to 2012, PharmAbcine Inc., as Director, Bicycle Therapeutics Plc, as Independent Director, CUTISS AG, as Director, and McKinsey & Co., Inc., as Associate Partner.
Dr. Koenig received her graduate degree from Ludwig-Maximilians-Universität München.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SENSIRION HOLDING AG 0,01 % | 31/12/2025 | 1 157 ( 0,01 % ) | 123 940 $ | 31/05/2026 |
Postes actifs de Anja Koenig
| Sociétés | Poste | Début |
|---|---|---|
| SENSIRION HOLDING AG | Directeur/Membre du Conseil | 18/05/2021 |
Novartis Venture Funds
 Novartis Venture Funds Investment ManagersFinance NVF invests in companies located across North America and Europe. The firm focuses on biotechnology & biopharmaceutical and Life science sectors. It provides financing for early and later stage transactions with an investment size up to USD 30 million per company and also acts as lead or co-lead investor. The firm takes a seat on the board of directors. | Private Equity Investor | 01/01/2007 |
Swiss National Science Foundation
 Swiss National Science Foundation Founded in 1952, the Swiss National Science Foundation (SNSF) is Switzerland’s primary organization dedicated to funding and promoting scientific research across all disciplines at universities and research institutions. The non-profit company is based in Bern, Switzerland. Operating as a private law foundation with a public mandate, SNSF invests substantial federal funds in basic and use-inspired research, supporting new projects and fellowships annually. Its governance includes a foundation council, delegates assembly, research council, and administrative offices, which oversee strategic direction, policy setting, and fair evaluation of funding applications. The research council manages the assessment of thousands of proposals each year, emphasizing transparency, equality, diversity, and international collaboration. SNSF offers diverse funding schemes, supports researchers throughout project lifecycles, and mandates open access publication of all funded research outputs. It promotes responsible research practices, supports early-career researchers, and fosters public engagement through various initiatives and communication channels. | Corporate Officer/Principal | - |
Arctos Medical AG
 Arctos Medical AG BiotechnologyHealth Technology Develops blindness gene therapies | Directeur/Membre du Conseil | - |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops cacner therapies | Directeur/Membre du Conseil | 04/01/2019 |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Directeur/Membre du Conseil | - |
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Directeur/Membre du Conseil | - |
Anciens postes connus de Anja Koenig
| Sociétés | Poste | Fin |
|---|---|---|
CUTISS AG
 CUTISS AG BiotechnologyHealth Technology Operates as a late-stage clinical TechBio company that develops skin tissue therapeutics and dedicated to bioengineering | Directeur/Membre du Conseil | 01/10/2018 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Anja Koenig
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance NVF invests in companies located across North America and Europe. The firm focuses on biotechnology & biopharmaceutical and Life science sectors. It provides financing for early and later stage transactions with an investment size up to USD 30 million per company and also acts as lead or co-lead investor. The firm takes a seat on the board of directors. | Finance |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MerLion Pharmaceuticals Pte Ltd.
 MerLion Pharmaceuticals Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibiotics | Health Technology |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Develops next generation protein drugs for the treatment of inflammatory diseases and cancer | Health Technology |
Diagnoplex SA
 Diagnoplex SA Medical SpecialtiesHealth Technology Develops molecular diagnostics for colon cancer | Health Technology |
PharmAbcine Inc.
 PharmAbcine Inc. BiotechnologyHealth Technology Develops human therapeutic monoclonal antibody for the treatment of cancer and inflammatory diseases | Health Technology |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Swiss National Science Foundation
Swiss National Science Foundation Founded in 1952, the Swiss National Science Foundation (SNSF) is Switzerland’s primary organization dedicated to funding and promoting scientific research across all disciplines at universities and research institutions. The non-profit company is based in Bern, Switzerland. Operating as a private law foundation with a public mandate, SNSF invests substantial federal funds in basic and use-inspired research, supporting new projects and fellowships annually. Its governance includes a foundation council, delegates assembly, research council, and administrative offices, which oversee strategic direction, policy setting, and fair evaluation of funding applications. The research council manages the assessment of thousands of proposals each year, emphasizing transparency, equality, diversity, and international collaboration. SNSF offers diverse funding schemes, supports researchers throughout project lifecycles, and mandates open access publication of all funded research outputs. It promotes responsible research practices, supports early-career researchers, and fosters public engagement through various initiatives and communication channels. | |
Sensirion Holding AG
 Sensirion Holding AG SemiconductorsElectronic Technology Manufactures and distributes digital micro-sensors & systems | Electronic Technology |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Health Technology |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops cacner therapies | Health Technology |
CUTISS AG
CUTISS AG BiotechnologyHealth Technology Operates as a late-stage clinical TechBio company that develops skin tissue therapeutics and dedicated to bioengineering | Health Technology |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic | Health Technology |
Arctos Medical AG
Arctos Medical AG BiotechnologyHealth Technology Develops blindness gene therapies | Health Technology |
